
Inscripta
Developing speech recognition solutions for healthcare and other enterprise grade use.
- B2B
- saas
- subscription
- health
- health platform
- artificial intelligence
- machine learning
- natural language processing
- recognition technology
- mobile app
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor investor investor investor investor | €0.0 | round |
investor investor | €0.0 | round | |
investor | €0.0 | round | |
investor investor investor investor investor | €0.0 | round | |
€700k | Angel | ||
Total Funding | 000k |
EUR | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | 371 % | 163 % | 69 % | 19 % | 40 % | 34 % | 88 % |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | (203 %) | (209 %) | (42 %) | (71 %) | (29 %) | - | - |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | (229 %) | (234 %) | (61 %) | (95 %) | (44 %) | - | - |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
R&D % of revenue | 100 % | - | - | - | - | - | - |
Source: Company filings or news article, Dealroom estimates
Related Content
Inscripta, founded in Helsinki in 2015 by Simo Sorsakivi, provides technology-assisted transcription and speech recognition services tailored for sectors where manual documentation is a significant time constraint for highly skilled professionals. The company primarily targets the healthcare, social care, and legal industries, serving both public and private entities. Its business model is centered on a B2B and B2G approach, offering a proprietary AI-powered solution to enhance documentation efficiency.
The core service, Inscripta Direct, enables professionals like doctors, nurses, and social workers to dictate notes directly into patient record systems in real-time. This tool is designed to be independent of existing EHR solutions for storing and sharing patient data. The company claims its application can save users an average of 45 minutes daily, allowing them to redirect their focus to client interaction and patient care. The platform is engineered to address challenges of accuracy and language adaptability in speech recognition. Revenue is generated through this service, which aims to make documentation workflows faster and more reliable.
Since its inception, Inscripta has secured approximately $853K in funding over two rounds, including an angel round in May 2021 that raised $853K. Key investors include Startup Creasphere, Founders' Edge, Icebreaker, and Winterbackwoods. The company's technology is developed in-house by a team of experts, with a commitment to continually improving the AI to meet the specific demands of professional documentation. All user data is stored securely within the EU to comply with stringent data protection and privacy standards.
Keywords: speech recognition, medical transcription, legal transcription, healthcare documentation, clinical documentation, dictation software, AI transcription, social care documentation, patient record systems, workflow optimization, B2B SaaS, healthcare technology, legal tech, professional documentation, documentation automation, Finnish startup, Simo Sorsakivi, voice to text, clinical notes, documentation efficiency